Cutting Edge: mTORC1 Inhibition in Metastatic Breast Cancer Patients Negatively Affects Peripheral NK Cell Maturation and Number.

Besson L, Mery B, Morelle M, Rocca Y, Heudel PE, You B, Bachelot T, Ray-Coquard I, Villard M, Charrier E, Parant F, Viel S, Garin G, Mayet R, Perol D, Walzer T, Tredan O, Marçais A.